A5 Laboratories Inc.

Symbol: AFLB

Current Price: $0.88

Snapshot - "AFLB is in a very nice chart pattern right now after starting to trend higher and we could see it go to $1.00 quickly! We believe AFLB could become our next monster trade. AFLB has been moving forward strongly in the biotech space after acquiring the biotech assets of a group called Contract Research during mid-July. AFLB has been seeing increased attention and we believe it is ready to see even more price increasing attention! AFLB is a ground floor opportunity to get positioned under $1.00 in a hot biotech stock!"

This stock has a lot of big potential that we love to see. We predict that AFLB could become one of our biggest biotech winners of all-time.

On July 12th, AFLB completed the acquisition of biotech assets from a group called Contract Research.

With the acquisition of Contract Research, AFLB has the assets at their disposal to develop and commercialize novel biotechnology products.

Within their new asset purchase is Interferon production technology. Interferon's can inhibit viruses from spreading to neighboring cells and it can aid in destroying cancerous cells.

Commercialization of Interferon is ground breaking including treatment for viral infections such as hepatitis C and as a treatment for certain cancers.

With the Contract Research acquisition, AFLB has established the capacity for contract analytical, product development, regulatory and testing services in the pharmaceutical and environmental sector.

It is still early in the game with AFLB and we see this stock going much higher. Investors are discovering it and we believe as more people discover it, and realize how attractive it is, we could see AFLB trading at new highs.

AFLB is incredibly attractive. AFLB signed an analytical services contract with BioActif, Inc. on July 20th. AFLB will provide comprehensive analytical and development services for BioActif.

AFLB's client, BioActif, owns, markets and distributes some of the most respected premium brands of pharmaceutical, cosmetics and nutraceutical products throughout Quebec, Canada.

Three research firms have initiated coverage of AFLB over the past nine trading days! This stock is getting picked up and noticed!

A move to over $1.00 could lead to a strong breakout in AFLB shares!

Check out our winning Stock Newsletter for alerts on AFLB.